Fed up with the ever-rising prices Big Pharmas are charging for drugs, billionaire investor Warren Buffett, Amazon CEO Jeff Bezos and JPMorgan’s Jamie Dimon earlier this year said they would form an independent health-care company designed to bring down the cost of medicine and improve services for their employees. This Forbes headline was priceless: "Disruption, Thy Name is Bezos ... and Dimon and Buffett!" The jury is out on whether they can revolutionise American health care and figure out a way to deliver what the US government hasn’t ... or can’t. The trio, of course, have something else in common. They tend to use lengthy letter formats to (in equal measure) opine and dole out guidance about global events, management principles, investment strategy and other nuggets. Bezos’ annual shareholder letter is the second most-anticipated CEO missive of the year, behind the annual Berkshire Hathaway letter by Buffett — and it came out last week. Granted, when you’re the richest man in ...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.